Medicare Will Cover Prostate Cancer Drug

View Comments
(credit: CBS)

(credit: CBS)

Medicare announced Thursday it will cover Dendreon’s prostate cancer drug Provenge, which has been shown to extend life for about four months for patients with late stages of the disease but costs up to $93,000.

Read more from the

View Comments
blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 1,917 other followers